Ergoteles’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ergoteles’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-89,800	Closed	-$267K	–	1897
2021 Q2	$267K	Buy	+89,800	New	+$313K	0.01%	1128

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles's CEMI Position: Q3 2021 in Review

Ergoteles sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2021, closing a stake of 89,800 shares — an estimated $267K sold.

Ergoteles first reported a position in CEMI in Q2 2021 and held it in 1 quarter. The position peaked at $267K in Q2 2021. 47 funds tracked by Wall St. Rank hold CEMI as of Q3 2021.

Ergoteles reported no remaining Chembio diagnostics, Inc. position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 89,800 Chembio diagnostics, Inc. shares in Q3 2021, an estimated $267K.
Ergoteles first reported a position in Chembio diagnostics, Inc. in Q2 2021 and held it in 1 quarter.
Ergoteles's Chembio diagnostics, Inc. position peaked at $267K in Q2 2021.
47 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.